Table 1 of
Sheereen, Mol Vis 2011; 17:3523-3528. Table 1 of
Sheereen, Mol Vis 2011; 17:3523-3528.
Table 1. Comparison of HLA-class I (-Cw) and KIR - HLA-C complex in a cohort of Saudi patients with VKH disease and control subjects.
| Controls (n=125) | VKH patients (n=30) | |||||
|---|---|---|---|---|---|---|
| HLA-C/KIR-HLA Complex | (N+) | %F | (N+) | %F | p-value | OD 95%(CI) |
| HLA-Cw* | ||||||
| HLA-C1/C1 | 26 | 20.8 | 1 | 3.3 | 0.0291 | 0.13 (0.017–1.009) |
| HLA-C1/C2 | 63 | 50.4 | 12 | 40 | ||
| HLA-C2/C2 | 36 | 28.8 | 17 | 56.7 | 0.0054 | 3.23 (1.42–7.33) |
| KIR-HLA(KIR ligand) | ||||||
| KIR2DL2/3-HLA-C1 | 88 | 70.4 | 14 | 46.7 | 0.0184 | 0.367 (0.163–0.830) |
| KIR2DL1-HLA-C2 | 97 | 77.6 | 28 | 93.3 | ||
| KIR2DS2-HLA-C1 | 52 | 41.6 | 9 | 30 | ||
| KIR2DS1-HLA-C2 | 32 | 25.6 | 8 | 26.7 | ||